Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000265535 | SCV000366038 | uncertain significance | Dilated Cardiomyopathy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000265535 | SCV000366042 | uncertain significance | Dilated Cardiomyopathy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000455661 | SCV000538286 | benign | not specified | 2016-04-25 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Genome Diagnostics Laboratory, |
RCV000603001 | SCV000743704 | benign | Congenital total pulmonary venous return anomaly | 2016-09-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001612950 | SCV001837497 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002056151 | SCV002438242 | benign | ANKRD1-related dilated cardiomyopathy | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002460066 | SCV002618363 | likely benign | Cardiovascular phenotype | 2015-09-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003983002 | SCV004796358 | benign | ANKRD1-related disorder | 2022-07-03 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV000603001 | SCV000732971 | benign | Congenital total pulmonary venous return anomaly | no assertion criteria provided | clinical testing |